FARGION, SILVIA ROSSANA

FARGION, SILVIA ROSSANA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 448 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors 2024 Lombardi, RosaCespiati, AnnalisaFrancione, PaoloDel Zanna, ElenaOrsi, EmanuelaGrancini, ValeriaFargion, SilviaFracanzani, Anna Ludovica + Article (author) -
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 2022 M. MeroniE. PaoliniM. LongoR. PiciottiS. FargionA. Ludovica FracanzaniP. Dongiovanni + Article (author) -
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 2022 Cinque F.Cespiati A.Lombardi R.Costantino A.Maffi G.Alletto F.Colavolpe L.Francione P.Oberti G.Fatta E.Bertelli C.Sigon G.Dongiovanni P.Vecchi M.Fargion S.Fracanzani A. L. Article (author) -
{PD}-1/{PD}-L1 Immuno-Mediated Therapy in {NAFLD}: Advantages and Obstacles in the Treatment of Advanced Disease 2022 Rosa LombardiRoberto PiciottiPaola DongiovanniMarica MeroniSilvia FargionAnna Ludovica Fracanzani Article (author) -
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD 2021 Dongiovanni P.Pelusi S.Rametta R.Fracanzani A. L.Fargion S.Valenti L. + Article (author) -
Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis 2021 Lombardi, RosaFargion, SilviaFracanzani, Anna Ludovica + Article (author) -
MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality? 2021 Lombardi, RosaCespiati, AnnalisaFrancione, PaoloCinque, FeliceFargion, SilviaFracanzani, Anna Ludovica Article (author) -
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) 2021 Cespiati, AnnalisaLombardi, RosaBertelli, CristinaPisano, GiuseppinaFatta, ErikaSigon, GiordanoIuculano, FedericaFrancione, PaoloFargion, SilviaFracanzani, Anna Ludovica + Article (author) -
Genetics, immunity and nutrition boost the switching from nash to hcc 2021 Dongiovanni P.Longo M.Fargion S.Fracanzani A. L. + Article (author) -
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD 2020 Dongiovanni P.Meroni M.Longo M.Valenti L.Miele L.Fargion S.Fracanzani A. L. + Article (author) -
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 2020 Lombardi R.Orsi E.Fargion S.Fracanzani A. L. + Article (author) -
Dysmetabolic hyperferritinemia and dysmetabolic iron overload syndrome (Dios): Two related conditions or different entities? 2020 Rametta R.Fracanzani A. L.Fargion S.Dongiovanni P. Article (author) -
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 2020 Lombardi R.Villani R.Rinaldi L.Orsi E.Fargion S.Fracanzani A. L. + Article (author) -
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation : preliminary results 2020 Pisano G.Oberti G.Borroni V.Lombardi R.Invernizzi F.Bertelli C.Porzio M.Dondossola D.Rossi G.Fargion S.Fracanzani A. L. + Article (author) -
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage 2020 Lombardi R.Pisano G.Dongiovanni P.Valenti L.Fargion S.Fracanzani A. L. + Article (author) -
Liver involvement in Gaucher disease : a practical review for the hepatologist and the gastroenterologist 2020 Cappellini M. D.Fargion S.Fracanzani A. L. + Article (author) -
Impact of natural neuromedin-B receptor variants on iron metabolism 2020 Rametta R.Dongiovanni P.Baselli G. A.Pelusi S.Meroni M.Fracanzani A. L.Fargion S.Valenti L. + Article (author) -
Nutrients, genetic factors, and their interaction in non-alcoholic fatty liver disease and cardiovascular disease 2020 Lombardi R.Iuculano F.Pallini G.Fargion S.Fracanzani A. L. Article (author) -
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 2019 Pelusi, SCespiati, ARametta, RBaselli, GDongiovanni, PFracanzani, A LBadiali, SFargion, SValenti, Luca + Article (author) -
Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis 2019 SIGON, GIORDANOD'Ambrosio, RobertaPisano, GiuseppinaLombardi, RosaPeyvandi, FloraLampertico, PietroFargion, SilviaTripodi, ArmandoFracanzani, Anna Ludovica + Article (author) -